A new study published in JAMA Psychiatry provides evidence that young adults at risk of developing psychosis show reduced ...

A new study has identified three psychological profiles that influence brain health, cognitive decline, and dementia risk in ...

For Medicaid beneficiaries with schizophrenia, delivery of mental health care through telehealth (telemental health care) ...

Researchers from Singapore's National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with ...

The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.

Medically reviewed by Dakari Quimby, PhD Psychosis and schizophrenia are related but distinct mental health conditions ...

Bristol Myers Squibb CEO Chris Boerner described Cobenfy, a new drug to treat schizophrenia and may also help with bipolar ...

In those with first episode psychosis, a long duration of untreated psychosis was linked to negative psychotic symptoms and lower symptom remission.

Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription ...